VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
HCXYHercules Capital, Inc.
$25.10$3.5B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

HCXY logoHercules Capital, Inc.(HCXY)Earnings, Financials & Key Ratios

HCXY•NYSE•Banking & Credit
13.6× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustryAsset ManagementSub-IndustryPrivate credit and BDC lenders
AboutHercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million and $250 million in equity per transactions. It invests generally between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in North America and Europe.Show more
  • Net Interest Income$416M
  • Total Revenue$492M+18.3%
  • Net Income$340M+30.6%
  • Return on Equity16.16%+17.8%
  • Net Interest Margin9.07%
  • Efficiency Ratio9.78%-67.3%
  • ROA8.07%+12.5%
  • Equity / Assets48.34%-6.9%
  • Book Value per Share11.73-4.7%

HCXY Key Insights

Hercules Capital, Inc. (HCXY) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong NIM of 9.1%
  • ✓Efficient operations: 9.8% efficiency ratio
  • ✓Well capitalized: 48.3% equity/assets
  • ✓Good 3Y average ROE of 17.0%
  • ✓Healthy dividend yield of 5.8%
  • ✓Trading near 52-week high

✗Weaknesses

  • ✗Shares diluted 16.9% in last year

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when HCXY posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

HCXY Price & Volume

Hercules Capital, Inc. (HCXY) stock price & volume — 10-year historical chart

Loading chart...

HCXY Growth Metrics

Hercules Capital, Inc. (HCXY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years17.78%
5 Years11.36%
3 Years15.21%
TTM-

Profit CAGR

10 Years22.99%
5 Years8.37%
3 Years49.3%
TTM28.86%

EPS CAGR

10 Years12.11%
5 Years-1.65%
3 Years14.27%
TTM13.66%

Return on Capital

10 Years8.44%
5 Years9.66%
3 Years9.7%
Last Year10.36%

HCXY Recent Earnings

Hercules Capital, Inc. (HCXY) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 1/9 qtrs (20%)●Beat Revenue 0/9 qtrs (0%)
Q2 2026Latest
Apr 30, 2026
Metric
Actual
Est
EPS
$0.23-52.0%
$0.48
Rev
$123M-12.5%
$141M
Q1 2026
Feb 12, 2026
Metric
Actual
Est
EPS
$0.48-2.5%
$0.49
Rev
$137M-2.9%
$142M
Q4 2025
Oct 30, 2025
Metric
Actual
Est
EPS
$0.61+27.3%
$0.48
Rev
$117M-14.8%
$137M
Q3 2025
Jul 31, 2025
Metric
Actual
Est
EPS
$0.41-12.9%
$0.47
Rev
$80M-38.1%
$129M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 30, 2026
$0.23vs $0.48-52.0%
$123Mvs $141M-12.5%
Q1 2026Feb 12, 2026
$0.48vs $0.49-2.5%
$137Mvs $142M-2.9%
Q4 2025Oct 30, 2025
$0.61vs $0.48+27.3%
$117Mvs $137M-14.8%
Q3 2025Jul 31, 2025
$0.41vs $0.47-12.9%
$80Mvs $129M-38.1%
Based on last 9 quarters of dataView full earnings history →

HCXY Peer Comparison

Hercules Capital, Inc. (HCXY) competitors in Private credit and BDC lenders — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
ARCC logoARCCAres Capital CorporationDirect Competitor12.95B18.039.6932.87%43.69%8.11%1.12
GBDC logoGBDCGolub Capital BDC, Inc.Direct Competitor3.22B12.358.7042.5%26.91%5.24%1.23
TPVG logoTPVGTriplePoint Venture Growth BDC Corp.Direct Competitor202.99M5.004.1036.55%-19.55%-3.39%1.33
HTGC logoHTGCHercules Capital, Inc.Direct Competitor2.9B15.498.3726.97%50.05%13.18%1.04
CGBD logoCGBDCarlyle Secured Lending, Inc.Direct Competitor760.99M10.9510.8417.9%23.81%4.42%1.31
SLRC logoSLRCSLR Investment Corp.Direct Competitor677.57M12.427.3124.76%39.78%7.31%1.15
MAIN logoMAINMain Street Capital CorporationProduct Competitor4.74B50.979.23-11.06%58.59%14.32%0.82
FSK logoFSKFS KKR Capital Corp.Product Competitor2.88B10.27261.325.5%-91.82%-9.39%1.31

Compare HCXY vs Peers

Hercules Capital, Inc. (HCXY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ARCC

Most directly comparable listed peer for HCXY.

Scale Benchmark

vs KKR

Larger-name benchmark to compare HCXY against a more recognizable public peer.

Peer Set

Compare Top 5

vs ARCC, GBDC, TPVG, HTGC

HCXY Income Statement

Hercules Capital, Inc. (HCXY) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Net Interest Income
134.34M151.2M192.92M203.77M198.91M252.51M366.81M0415.71M
NII Growth %
6.02%12.55%27.59%5.63%-2.39%26.94%45.26%-100%-
Net Interest Margin %
8.12%7.77%7.84%7.77%7.65%8.34%10.73%0%9.07%
Interest Income
172.2M190.64M247.51M263.38M253.36M307.26M434.43M0507.89M
Interest Expense
37.86M39.44M54.6M59.6M54.45M54.75M67.62M092.18M
Loan Loss Provision
-13.3M-14.37M-54.6M-59.6M-54.45M-54.75M-67.62M54.23M-80.49M
Non-Interest Income
-36.62M-54.55M20.36M23.88M27.62M14.43M26.24M415.93M-16M
Non-Interest Income %
-27.01%-40.09%7.6%8.31%9.83%4.49%5.7%100%-3.25%
Total Revenue
135.58M▲ 0%
136.09M▲ 0.4%
267.87M▲ 96.8%
287.26M▲ 7.2%
280.98M▼ 2.2%
321.69M▲ 14.5%
460.67M▲ 43.2%
415.93M▼ 9.7%
491.88M▲ 18.3%
Revenue Growth %
21.71%0.37%96.84%7.24%-2.19%14.49%43.2%-9.71%18.26%
Non-Interest Expense
56.58M59.59M60.7M58.96M59.98M65.86M73.09M124.31M48.1M
Efficiency Ratio
41.73%43.79%22.66%20.52%21.35%20.47%15.87%29.89%9.78%
Operating Income
67.8M▲ 0%
115.93M▲ 71.0%
207.17M▲ 78.7%
228.3M▲ 10.2%
221M▼ 3.2%
255.83M▲ 15.8%
387.57M▲ 51.5%
237.39M▼ 38.8%
432.1M▲ 82.0%
Operating Margin %
50.01%85.19%77.34%79.48%78.65%79.53%84.13%57.07%87.85%
Operating Income Growth %
-10.81%70.99%78.7%10.2%-3.2%15.76%51.5%-38.75%82.02%
Pretax Income
79M▲ 0%
76.5M▼ 3.2%
173.6M▲ 126.9%
227.26M▲ 30.9%
174.16M▼ 23.4%
102.08M▼ 41.4%
337.48M▲ 230.6%
262.97M▼ 22.1%
339.74M▲ 29.2%
Pretax Margin %
58.27%56.21%64.81%79.11%61.98%31.73%73.26%63.22%69.07%
Income Tax
49.05M37.86K0000000
Effective Tax Rate %
62.1%0.05%0%0%0%0%0%0%0%
Net Income
79M▲ 0%
76.5M▼ 3.2%
173.6M▲ 126.9%
227.26M▲ 30.9%
174.16M▼ 23.4%
102.08M▼ 41.4%
337.48M▲ 230.6%
260.13M▼ 22.9%
339.74M▲ 30.6%
Net Margin %
58.27%56.21%64.81%79.11%61.98%31.73%73.26%62.54%69.07%
Net Income Growth %
14.98%-3.17%126.94%30.91%-23.37%-41.38%230.6%-22.92%30.6%
Net Income (Continuing)
79M76.5M173.6M227.26M174.16M102.08M337.48M262.97M339.74M
EPS (Diluted)
0.95▲ 0%
0.84▼ 11.6%
1.71▲ 103.6%
2.01▲ 17.5%
1.49▼ 25.9%
1.24▼ 16.8%
2.31▲ 86.3%
1.61▼ 30.3%
1.85▲ 14.9%
EPS Growth %
4.4%-11.58%103.57%17.54%-25.87%-16.78%86.29%-30.3%14.91%
EPS (Basic)
0.950.841.712.021.501.252.321.611.90
Diluted Shares Outstanding
82.64M91.06M101.57M112.27M115.95M126.66M144.83M161.6M188.86M

HCXY Balance Sheet

Hercules Capital, Inc. (HCXY) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash & Short Term Investments
91.31M34.21M64.39M198.28M133.12M15.8M98.9M113.12M56.87M
Cash & Due from Banks
91.31M34.21M64.39M198.28M133.12M15.8M98.9M113.12M56.87M
Short Term Investments
000000000
Total Investments
1.54B1.88B2.31B2.35B2.43B2.96B3.25B3.66B4.47B
Investments Growth %
8.31%21.93%23.09%1.71%3.42%21.75%9.58%12.68%22.04%
Long-Term Investments
1.54B1.88B2.31B2.35B2.43B2.96B3.25B3.66B4.47B
Accounts Receivables
12.26M16.96M20.21M19.08M17.36M31.68M32.74M32.58M37.26M
Goodwill & Intangibles
000000000
Goodwill
000000000
Intangible Assets
000000000
PP&E (Net)
0011.66M9.28M6.76M4.99M4.79M16.78M14.84M
Other Assets
-1.65B-1.95B580K3.88M4.54M1.48M4.45M5.68M-4.47B
Total Current Assets
103.57M51.17M135.2M256.76M154.19M58.43M131.64M149.15M94.14M
Total Non-Current Assets
1.54B1.88B2.33B2.37B2.45B2.97B3.26B3.68B14.84M
Total Assets
1.65B▲ 0%
1.95B▲ 17.6%
2.46B▲ 26.6%
2.62B▲ 6.6%
2.6B▼ 0.9%
3.03B▲ 16.5%
3.42B▲ 12.8%
3.83B▲ 12.1%
4.58B▲ 19.6%
Asset Growth %
13.01%17.55%26.57%6.58%-0.91%16.49%12.81%12.14%19.64%
Return on Assets (ROA)
5.07%4.25%7.88%8.94%6.67%3.63%10.47%7.18%8.07%
Accounts Payable
26.9M25.96M30.31M36.34M42.08M46.34M54.16M54.36M65.26M
Total Debt
786.85M963.79M1.3B1.3B1.24B1.58B1.56B1.79B2.3B
Net Debt
695.54M929.57M1.23B1.1B1.11B1.56B1.46B1.67B2.25B
Long-Term Debt
786.85M963.79M1.29B1.29B857M1.57B1.55B1.77B1.86B
Short-Term Debt
0000379.3M000424.27M
Other Liabilities
-196.59M-199.09M0000-104.83M052.17M
Total Current Liabilities
223.49M78.92M30.31M36.34M427.08M47.54M5.2M57.95M16.27M
Total Non-Current Liabilities
590.26M963.79M1.3B1.3B864.38M1.58B1.45B1.78B2.35B
Total Liabilities
813.75M989.75M1.33B1.33B1.29B1.63B1.61B1.84B2.37B
Total Equity
1.53B▲ 0%
1.87B▲ 22.2%
1.13B▼ 39.5%
1.29B▲ 14.0%
1.31B▲ 1.3%
1.4B▲ 7.1%
1.8B▲ 28.6%
1.99B▲ 10.4%
2.22B▲ 11.4%
Equity Growth %
7.84%22.22%-39.52%14%1.3%7.1%28.63%10.37%11.38%
Equity / Assets (Capital Ratio)
92.63%96.31%46.02%49.23%50.33%46.27%52.76%51.93%48.34%
Return on Equity (ROE)
5.35%4.49%11.55%18.75%13.4%7.53%21.07%13.72%16.16%
Book Value per Share
18.5520.5711.1611.5111.2811.0612.4512.3111.73
Tangible BV per Share
18.5520.5711.1611.5111.2811.0612.4512.3111.73
Common Stock
85K96K108K115K117K134K158K171K183K
Additional Paid-in Capital
908.5M1.05B1.15B1.16B1.09B1.34B1.66B1.9B2.11B
Retained Earnings
32.52M-92.86M-12.16M133.39M216.52M59.91M140.01M88.92M101.15M
Accumulated OCI
-100.13M-123.53M0000000
Treasury Stock
0-4.06M0000000
Preferred Stock
32.52M123.53M0000000

HCXY Cash Flow Statement

Hercules Capital, Inc. (HCXY) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations
-18.4M-248.97M-240.66M155.04M128.62M-424.8M68.28M-118.09M-425.8M
Operating CF Growth %
86.7%-1253.1%3.34%164.42%-17.04%-430.27%116.07%-272.95%-260.58%
Net Income
79M76.5M173.6M225.65M174.16M102.08M337.48M262.97M40.61M
Depreciation & Amortization
201K199K262K415K7.36M5.88M7.17M7.42M-38.81M
Deferred Taxes
-89.7M-326.49M-424.94M000000
Other Non-Cash Items
-18.13M-5.1M-1.64M-76.77M-78.22M-529.91M-272.45M-416.74M-448.29M
Working Capital Changes
2.98M-5.34M3.42M5.74M13.39M-16.23M-17.17M15.42M5.9M
Cash from Investing
4.36M-475K-595K52.62M-106K-114K-887K-705K-89K
Purchase of Investments
-764.79M-960.84M-1.03B-761.26M0000-1.7B
Sale/Maturity of Investments
23.88M19.89M39.57M814.02M0000120.9M
Net Investment Activity
-740.91M-940.96M-986.14M52.76M0000-1.58B
Acquisitions
740.91M475K595K000000
Other Investing
4.64M940.96M986.14M000001.58B
Cash from Financing
92.3M200.31M310.4M-85.04M-229.87M314.52M22.75M119.2M368.92M
Dividends Paid
-100.89M-112.72M-132.05M-152.42M-175.5M-245.12M-273.68M-303.48M-325.99M
Share Repurchases
-2.69M-4.96M-5.12M-1.84M-2.82M-4.53M-12.7M-3.43M-6.49M
Stock Issued
66.94M144.39M132.54M77.18M00000
Net Stock Activity
64.25M139.44M127.42M75.34M-2.82M-4.53M-12.7M-3.43M-6.49M
Debt Issuance (Net)
1000K1000K1000K-1000K-1000K1000K-1000K1000K1000K
Other Financing
60.67M144.16M00-1.49M221.14M333.13M212.48M189.88M
Net Change in Cash
78.27M▲ 0%
-49.14M▼ 162.8%
69.14M▲ 240.7%
122.63M▲ 77.4%
-101.36M▼ 182.7%
-110.39M▼ 8.9%
90.14M▲ 181.7%
408K▼ 99.5%
-56.97M▼ 14062.5%
Exchange Rate Effect
000000000
Cash at Beginning
13.04M95M45.86M115M237.62M136.26M25.88M116.01M116.42M
Cash at End
91.31M45.86M115M237.62M136.26M25.88M116.01M116.42M59.45M
Interest Paid
000051.47M52.08M67.15M77.85M0
Income Taxes Paid
000000000
Free Cash Flow
-18.67M▲ 0%
-249.44M▼ 1235.8%
-241.26M▲ 3.3%
154.91M▲ 164.2%
128.51M▼ 17.0%
-424.91M▼ 430.6%
67.39M▲ 115.9%
-118.79M▼ 276.3%
-425.8M▼ 258.4%
FCF Growth %
86.53%-1235.79%3.28%164.21%-17.04%-430.63%115.86%-276.27%-258.44%

HCXY Banking Ratios

Hercules Capital, Inc. (HCXY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)
6.43%5.35%4.49%11.55%18.75%13.4%7.53%21.07%13.72%16.16%
Return on Assets (ROA)
4.91%5.07%4.25%7.88%8.94%6.67%3.63%10.47%7.18%8.07%
Net Interest Margin
8.65%8.12%7.77%7.84%7.77%7.65%8.34%10.73%0%9.07%
Efficiency Ratio
38.32%41.73%43.79%22.66%20.52%21.35%20.47%15.87%29.89%9.78%
Equity / Assets
97.07%92.63%96.31%46.02%49.23%50.33%46.27%52.76%51.93%48.34%
Book Value / Share
19.2718.5520.5711.1611.5111.2811.0612.4512.3111.73
NII Growth
15.79%6.02%12.55%27.59%5.63%-2.39%26.94%45.26%-100%-
Dividend Payout
131.78%127.71%147.36%76.07%-83.48%165.87%67.21%96.66%81.26%
Related:HCXY Dividend History·HCXY Revenue History·HCXY Price History·HCXY P/E History·HCXY Financial Ratios·HCXY Institutional Holders

HCXY SEC Filings & Documents

Hercules Capital, Inc. (HCXY) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Feb 12, 2026·SEC

Material company update

Feb 10, 2026·SEC

Material company update

Feb 3, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 12, 2026·SEC

FY 2025

Feb 13, 2025·SEC

FY 2024

Feb 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 31, 2025·SEC

FY 2025

May 1, 2025·SEC

HCXY Frequently Asked Questions

Hercules Capital, Inc. (HCXY) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Hercules Capital, Inc. (HCXY) grew revenue by 18.3% over the past year. This is strong growth.

Yes, Hercules Capital, Inc. (HCXY) is profitable, generating $338.8M in net income for fiscal year 2025 (69.1% net margin).

Dividend & Returns

Yes, Hercules Capital, Inc. (HCXY) pays a dividend with a yield of 5.82%. This makes it attractive for income-focused investors.

Hercules Capital, Inc. (HCXY) has a return on equity (ROE) of 16.2%. This is reasonable for most industries.

Industry Metrics

Hercules Capital, Inc. (HCXY) has a net interest margin (NIM) of 9.1%. This indicates healthy earnings from lending activities.

Hercules Capital, Inc. (HCXY) has an efficiency ratio of 9.8%. This is excellent, indicating strong cost control.

What if you invested $1,000 in HCXY back in 2004?

Total return calculator · dividends reinvested · 22+ years of data

See returns →

How much would $100/month in HCXY be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →